- Home
- MDGL vs OGE Comparison
MDGL vs OGE Comparison
Compare MDGL & OGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | OGE |
|---|---|---|
| Founded | 2011 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.8B |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MDGL | OGE |
|---|---|---|
| Price | $549.60 | $48.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $674.45 | $48.78 |
| AVG Volume (30 Days) | 306.0K | ★ 1.2M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.59% |
| EPS Growth | ★ 41.32 | 5.94 |
| EPS | N/A | ★ 0.24 |
| Revenue | $180,133,000.00 | ★ $3,260,100,000.00 |
| Revenue This Year | $58.39 | $3.74 |
| Revenue Next Year | $48.55 | $1.42 |
| P/E Ratio | ★ N/A | $202.13 |
| Revenue Growth | N/A | ★ 9.21 |
| 52 Week Low | $286.75 | $41.70 |
| 52 Week High | $615.00 | $50.13 |
Technical Indicators
Market Signals| Indicator | MDGL | OGE |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 51.66 |
| Support Level | $498.59 | $48.12 |
| Resistance Level | $572.20 | $49.14 |
| Average True Range (ATR) | 21.95 | 0.75 |
| MACD | 5.25 | -0.01 |
| Stochastic Oscillator | 77.24 | 52.76 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.